<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03091894</url>
  </required_header>
  <id_info>
    <org_study_id>3-2017-021</org_study_id>
    <nct_id>NCT03091894</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine Added to Propofol for Drug Induced Sleep Endoscopy</brief_title>
  <official_title>Dexmedetomidine Added to Propofol for Drug Induced Sleep Endoscopy in Adult Patients With Obstructive Sleep Apnea: A Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Essam Fathi</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluate the effect of adding dexmedetomidine intravenous infusion to propofol
      intravenous infusion during sedation for drug induced sleep endoscopy. Twenty five patients
      will receive propofol only while the other twenty five will receive propofol and
      dexmedetomidine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Propofol is a commonly used intravenous anesthetic drug used for procedural sedation.
      Dexmedetomidine is an alpha 2 adrenergic receptor agonist which has a sedative and analgesic
      effects.In the current study the success of the sedation during drug induced sleep endoscopy
      will be assessed.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 9, 2017</start_date>
  <completion_date type="Actual">April 8, 2018</completion_date>
  <primary_completion_date type="Actual">April 8, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>success of sedation</measure>
    <time_frame>the duration of the procedure under sedation is usually about 20 minutes</time_frame>
    <description>to complete the procedure with diagnosis of site and degree of obstruction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>time until sufficient sedation</measure>
    <time_frame>about 5-10 minutes from start of sedation</time_frame>
    <description>time till patient is ready to start endoscopy</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">50</enrollment>
  <condition>Obstructive Sleep Apnea of Adult</condition>
  <arm_group>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients will receive only propofol intravenous infusion for sedation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>propofol-dex.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients will receive dexmedetomidine in addition to propofol intravenous infusion for sedation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Propofol</intervention_name>
    <description>propofol intravenous infusion via syringe pump with loading dose of 0.5 mg/kg over 3 minutes then continuous infusion in a dose of 25-75 ug/kg/minute</description>
    <arm_group_label>propofol</arm_group_label>
    <arm_group_label>propofol-dex.</arm_group_label>
    <other_name>diprivan</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>dexmedetomidine intravenous infusion via syringe pump with loading dose of 0.5ug/kg over 5 minutes the continuous infusion in a dose of 0.2-0.7ug/kg/hour in addition to the propofol infusion as in propofol group</description>
    <arm_group_label>propofol-dex.</arm_group_label>
    <other_name>precedex</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age more than 18 years

          -  patients with obstructive sleep apnea

          -  ASA 1and2

        Exclusion Criteria:

          -  patient refusal

          -  age less than 18 years

          -  morbid obesity

          -  known or suspected allergy to the studied drugs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>essam f abdelgalel, A.professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Zagazig university-faculty of medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Zagazig university</name>
      <address>
        <city>Zagazig</city>
        <state>Sharkia</state>
        <zip>002055</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 21, 2017</study_first_submitted>
  <study_first_submitted_qc>March 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 27, 2017</study_first_posted>
  <last_update_submitted>April 11, 2018</last_update_submitted>
  <last_update_submitted_qc>April 11, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>Essam Fathi</investigator_full_name>
    <investigator_title>assistent professor</investigator_title>
  </responsible_party>
  <keyword>Dexmedetomidine</keyword>
  <keyword>Sleep</keyword>
  <keyword>Endoscopy</keyword>
  <keyword>Propofol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Propofol</mesh_term>
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

